• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Obstruction/Occlusion (2422)
Event Date 11/20/2018
Event Type  Injury  
Event Description
(b)(6) clinical trial.It was reported that a vessel occlusion occurred.The patient underwent treatment with the eluvia device on (b)(6) 2017 as part of the regal clinical trial.The following lesion was treated in the left limb: proximal, middle and distal superficial femoral artery (proximal popliteal artery not involved).The lesion was 220mm long, 100% stenosed with a proximal reference diameter of 6mm and distal reference diameter of 5mm.Pre-dilatation was performed using a balloon and the lesion was crossed through the true lumen.Three eluvia drug eluting vascular stents 6mm x 100mm, 6mm x 80mm, and 6mm x 80mm were implanted in the target lesion.Post-dilatation was performed using one balloon.The residual stenosis was 0% and there was no thrombus seen in the treated vessel at the end of the procedure.On (b)(6) 2018, an occlusion in the target vessel was discovered.The patient was hospitalized on (b)(6) 2018 for a percutaneous transluminal angioplasty treatment with a drug eluting balloon at the deep left femoral artery.The patient was discharged on (b)(6) 2018 and the event is reported as resolved with sequelae.
 
Manufacturer Narrative
Patient identifier: (b)(6).Initial reporter facility name: (b)(6).Initial reporter phone: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13745594
MDR Text Key287910857
Report Number2134265-2022-02569
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeIT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/17/2019
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0020993693
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/23/2022
Initial Date FDA Received03/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient SexMale
-
-